Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
EMBO Molecular Medicine
|
July 23, 2019
An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
Morgane Morabito, Magalie Larcher, Florence Mg Cavalli, et al.
Cancer Cell
|
March 14, 2018
NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in Medulloblastoma
Alexandra Garancher, Charles Y Lin, Morgane Morabito, et al.
American Journal of Human Genetics
|
April 14, 2015
Mutations Impairing GSK3-Mediated MAF Phosphorylation Cause Cataract, Deafness, Intellectual Disability, Seizures, and a Down Syndrome-like Facies
Marcello Niceta, Emilia Stellacci, Karen W Gripp, et al.
Cancer Cell
|
November 12, 2019
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
Amaury Leruste, Jimena Tosello, Rodrigo Nalio Ramos, et al.
Cancer Research
|
July 25, 2025
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiation Therapy
Cory M Richman, Alexandra Rasnitsyn, Borja L Holgado, et al.
Neuro-Oncology
|
October 23, 2022
Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin
Satoshi Nakata, Junko Murai, Masayasu Okada, et al.
Cancer Cell
|
September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Antoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Nature Communications
|
September 23, 2021
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression
Jing Liu, Daniela Ottaviani, Meriem Sefta, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
EMBO Molecular Medicine
|
July 23, 2019
An autocrine ActivinB mechanism drives TGFβ/Activin signaling in Group 3 medulloblastoma
Morgane Morabito, Magalie Larcher, Florence Mg Cavalli, et al.
Cancer Cell
|
March 14, 2018
NRL and CRX Define Photoreceptor Identity and Reveal Subgroup-Specific Dependencies in Medulloblastoma
Alexandra Garancher, Charles Y Lin, Morgane Morabito, et al.
American Journal of Human Genetics
|
April 14, 2015
Mutations Impairing GSK3-Mediated MAF Phosphorylation Cause Cataract, Deafness, Intellectual Disability, Seizures, and a Down Syndrome-like Facies
Marcello Niceta, Emilia Stellacci, Karen W Gripp, et al.
Cancer Cell
|
November 12, 2019
Clonally Expanded T Cells Reveal Immunogenicity of Rhabdoid Tumors
Amaury Leruste, Jimena Tosello, Rodrigo Nalio Ramos, et al.
Cancer Research
|
July 25, 2025
Carbonic Anhydrase Inhibition Sensitizes Group 3 Medulloblastoma to Radiation Therapy
Cory M Richman, Alexandra Rasnitsyn, Borja L Holgado, et al.
Neuro-Oncology
|
October 23, 2022
Epigenetic upregulation of Schlafen11 renders WNT- and SHH-activated medulloblastomas sensitive to cisplatin
Satoshi Nakata, Junko Murai, Masayasu Okada, et al.
Cancer Cell
|
September 12, 2018
Aberrant ERBB4-SRC Signaling as a Hallmark of Group 4 Medulloblastoma Revealed by Integrative Phosphoproteomic Profiling
Antoine Forget, Loredana Martignetti, Stéphanie Puget, et al.
Nature Communications
|
September 23, 2021
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression
Jing Liu, Daniela Ottaviani, Meriem Sefta, et al.
Page
of 3